Maternal-fetal inflammation in the placenta and the developmental origins of health and disease

JA Goldstein, K Gallagher, C Beck, R Kumar… - Frontiers in …, 2020 - frontiersin.org
Events in fetal life impact long-term health outcomes. The placenta is the first organ to form
and is the site of juxtaposition between the maternal and fetal circulations. Most diseases of …

Chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome

EF Cornish, T McDonnell, DJ Williams - Frontiers in Immunology, 2022 - frontiersin.org
Chronic inflammatory placental disorders are a group of rare but devastating gestational
syndromes associated with adverse pregnancy outcome. This review focuses on three …

[HTML][HTML] FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal …

N Melamed, A Baschat, Y Yinon… - … of Gynaecology and …, 2021 - ncbi.nlm.nih.gov
Fetal growth restriction (FGR) is defined as the failure of the fetus to meet its growth potential
due to a pathological factor, most commonly placental dysfunction. Worldwide, FGR is a …

SARS–CoV-2 infection of the placenta

H Hosier, SF Farhadian, RA Morotti… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND The effects of the novel coronavirus disease 2019 (COVID-19) in pregnancy
remain relatively unknown. We present a case of second trimester pregnancy with …

Histopathological features of SARS-CoV-2 in extrapulmonary organ infection: A systematic review of literature

D Torge, S Bernardi, M Arcangeli, S Bianchi - Pathogens, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health concern
responsible for the ongoing pandemic. Histopathological pieces of evidence on COVID-19 …

Investigating the risk of maternal-fetal transmission of SARS-CoV-2 in early pregnancy

F Halici-Ozturk, FD Ocal, S Aydin, A Tanacan… - Placenta, 2021 - Elsevier
Introduction The possibility of vertical transmission of SARS-CoV-2 from the mother to the
fetus is one of the most crucial issues regarding the COVID-19 effects on pregnancy. In this …

Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis

L Moar, C Simela, S Nanda, A Marnerides… - Frontiers in …, 2022 - frontiersin.org
Background Chronic histiocytic intervillositis (CHI) is a rare placental lesion with a high
recurrence rate and poor perinatal outcomes. There are currently limited guidelines …

Inflammatory lesions in placental pathology

Y Sato - Journal of Obstetrics and Gynaecology Research, 2022 - Wiley Online Library
Placental inflammatory lesions are important findings that lead fetal and neonatal morbidity
and mortality, and can be divided into two broad subcategories, acute inflammation caused …

Reproductive and treatment outcomes in chronic intervillositis of unknown etiology: a systematic review and meta-analysis

N Simula, K McRae, R Habte, B Fayek, E Won… - Journal of Reproductive …, 2024 - Elsevier
Abstract Chronic Intervillositis of Unknown Etiology (CIUE) is a rare idiopathic inflammatory
disorder of the placenta. The evidence suggests an increased risk for poor obstetrical …

Immunomodulatory therapy reduces the severity of placental lesions in chronic histiocytic intervillositis

CA Brady, C Williams, G Batra, E Church… - Frontiers in …, 2021 - frontiersin.org
Chronic histiocytic intervillositis (CHI) is a rare, but highly recurrent inflammatory placental
lesion wherein maternal macrophages infiltrate the intervillous space. Pregnancies with CHI …